Appointment of Dr. Susanne Lenz complete construction from equity, technology and life sciences
FRANKFURT, Germany, April 4, 2022 /PRNewswire/ — Mayer Brown Capital Markets, a leading debt and equity capital markets firm advising clients across United States, Europe and Asiatoday strengthened the breadth of its offering with the hiring of Dr. Susanne Lenz.
Dr. Lenz is a qualified capital markets practitioner in Germany and New York. She will be based at Frankfurt and will focus on transactions in the equity and debt markets in both Germany and United States. His appointment further expands Mayer Brown’s growing European capabilities in advising companies on IPOs, private placements and other equity offerings, and complements his particular focus on equities, technology and life sciences. life.
Dr. Lenz advises issuers and underwriters on private placements, IPOs, registered follow-on stock offerings, rights issues, block trades, dual listings, convertible bonds, debt, as well as post-listing bonds in Germany and United States.
Dominic Griffithsmanaging partner of Mayer Brown’s London office said: “By welcoming Susanne, we are expanding our capital markets capabilities that we offer to our clients through Europe and complement our focus on equities, life sciences and technology.”
Earlier in 2022, Mayer Brown added a debt capital markets partner, Stone Pearsin his London Office. In GermanyDr. Lenz will be part of the highly regarded EU-focused German capital markets practice, which has also promoted Alexei Döhl to January 2022.
dr. Patrick Schollwho leads the German capital markets practice, said: “With the arrival of Susanne, our capital markets practice will be one of the few full-service offerings in our market and will create an important link with our transactions teams. corporate and financial led by Julien Lemor and Martin Heuber.”
Dr Lenz said: “I was drawn to Mayer Brown because of the talent of its people and the breadth of the company’s experience not only in capital markets but also with emerging companies. of technology and life sciences, making it an excellent choice for my practice and clients.”
Mayer Brown is widely recognized for his capital markets capabilities and is ranked by Chambers Global for its Finance & Capital Markets category (International & Cross-Border) and ranked by Chambers Europe for various capital markets categories in four jurisdictions.
Mayer Brown’s industry experience sets it apart from its competitors. The company is rated Band 1 by Chambers & Partners for technology and outsourcing in various geographies, including globally and Europe– extensive jurisdictions; and rated by the International Association of Outsourcing Professionals as one of the “Best Law Firms”. LMG Life Sciences 2021/22 includes 12 Mayer Brown associates as “Leading Life Sciences Lawyers”.
Mayer Brown is a global law firm uniquely positioned to advise the world’s largest corporations and financial institutions on their most complex transactions and disputes. With an extensive reach across four continents, we are the world’s only integrated law firm with approximately 200 attorneys in each of the world’s three largest financial centers – New York, London and Hong Kong, the backbone of the global economy. We have deep experience in high-stakes litigation and complex transactions across all industry sectors, including our signature strength, the global financial services industry. Our diverse teams of lawyers are recognized by our clients as strategic partners with deep business instincts and a commitment to creatively anticipating their needs and delivering excellence in everything we do. Our ‘One Company’ culture, consistent and integrated across all practices and regions, ensures that our clients receive the best of our knowledge and experience.
Please visit mayerbrown.com for complete contact information for all Mayer Brown offices.